Though much of the research around PDA and BPC-157 remains preliminary, studies and clinical observations suggest the following mechanisms: 1
Ligamentous laxity - Wikipedia Then there is the issue of TB 500 and the recently surfaced studies that point to the possibility of the compound spreading cancerous cells through the body
Preclinical (mostly rat) studies show BPC-157 acts like a supercharged project manager that: Builds new blood vessels super fast (angiogenesis) It switches on the VEGF system (the same one your body uses to grow new capillaries) and boosts nitric oxide so fresh blood, oxygen, and nutrients flood the injured area
Possible mild side effects (rare): Temporary nausea or digestive upset
Every intervention has tradeoffs, and you deserve to know exactly what they are
Individual results may vary significantly based on health status, injury type, and other factors